ライフサイエンスコーパス: mobility shift assay

1 ion of GATA3 was analysed by electrophoretic mobility shift assay.

2 h RvE1 treatment as shown in electrophoresis mobility shift assay.

3 ter regions was confirmed by electrophoretic mobility shift assay.

4 higher than for dsDNA in an electrophoretic mobility shift assay.

5 e-specific RNA binding in an electrophoretic mobility shift assay.

6 munoprecipitation (ChIP) and electrophoretic mobility shift assay.

7 er region was observed in an electrophoretic mobility shift assay.

8 ed elongation complexes as measured in a gel mobility shift assay.

9 bility to bind to the tcpA promoter in a gel mobility shift assay.

10 nd protein was determined by electrophoretic mobility shift assay.

11 terized by site-directed mutagenesis and gel mobility shift assay.

12 ated G or A alleles in a gel electrophoretic mobility shift assay.

13 to produce a shifted band by electrophoretic mobility shift assay.

14 atio was 50 as determined by electrophoretic mobility shift assay.

15 tometry, transactivation and electrophoretic mobility shift assays.

16 and PntR were identified by electrophoretic mobility shift assays.

17 transcriptase (qRT)-PCR, and electrophoretic mobility shift assays.

18 r the biotin operator DNA in electrophoretic mobility shift assays.

19 his location by ChIP-seq and electrophoretic mobility shift assays.

20 the CbbR-cbbLS promoter interactions in gel mobility shift assays.

21 d using light scattering and electrophoretic mobility shift assays.

22 nd to each of these sites in electrophoretic mobility shift assays.

23 the virB promoter region in electrophoretic mobility shift assays.

24 promoters in vitro by use of electrophoretic mobility shift assays.

25 egration sequences (attB) in electrophoretic mobility shift assays.

26 ties, which was confirmed by electrophoretic mobility shift assays.

27 atin immunoprecipitation and electrophoretic mobility shift assays.

28 within their promoters, as determined by gel mobility shift assays.

29 n polymerase chain reaction, immunoblot, and mobility shift assays.

30 ble complex with Bdnf RNA in electrophoretic mobility shift assays.

31 moter DNA was analyzed using electrophoretic mobility shift assays.

32 binding was investigated by electrophoretic mobility shift assays.

33 ctly bound only the proximal FixK box in gel mobility-shift assays.

34 Electrophoretic mobility shift assay analysis indicates that the SNP dif

35 Electrophoretic mobility shift assay analysis with antibodies against c-

36 ugh DNase I footprinting and electrophoretic mobility shift assay analysis.

37 F65, as determined by an RNA electrophoretic mobility shift assay and a chromatin immunoprecipitation

38 during di-snRNP assembly by electrophoretic mobility shift assay and accompanying conformational cha

39 nd loci were validated using electrophoretic mobility shift assay and ChIP-polymerase chain reaction

40 Electrophoretic mobility shift assay and chromatin immunoprecipitation a

41 Electrophoretic mobility shift assay and chromatin immunoprecipitation a

42 We then used an electrophoretic mobility shift assay and chromatin immunoprecipitation a

43 Electrophoretic mobility shift assay and chromatin immunoprecipitation a

44 vation studies combined with electrophoretic mobility shift assay and chromatin immunoprecipitation a

45 Promoter, electrophoretic mobility shift assay and chromatin immunoprecipitation a

46 promoter was corroborated by electrophoretic mobility shift assay and chromatin immunoprecipitation a

47 By electrophoretic mobility shift assay and chromatin immunoprecipitation c

48 Using mobility shift assay and chromatin immunoprecipitation,

49 C1 promoter was confirmed by electrophoretic mobility shift assay and chromatin immunoprecipitation.

50 h DNA-binding, which we confirmed by electro-mobility shift assay and isothermal titration calorimetr

51 NP function was evaluated by electrophoretic mobility shift assay and promoter luciferase assay.

52 The implementation of electrophorethic mobility shift assay and pull-down experiments coupled w

53 ctivate ODO1, as revealed by electrophoretic mobility shift assay and yeast one-hybrid analysis, plac

54 Here we demonstrate through mobility shift assays and calorimetric measurements that

55 ntified it using competitive electrophoretic mobility shift assays and chromatin immunoprecipitation.

56 promoter was verified using electrophoretic mobility shift assays and chromatin immunoprecipitation.

57 biquitin conjugation include electrophoretic mobility shift assays and detection of epitope-tagged or

58 te for BldD, as was shown by electrophoretic mobility shift assays and DNase I footprinting analysis.

59 Moreover, electrophoretic mobility shift assays and DNase I footprinting revealed

60 t of this competition model, electrophoretic mobility shift assays and DNase I footprinting showed th

61 within the cbbLS promoter by the use of gel mobility shift assays and DNase I footprinting.

62 Using electrophoretic mobility shift assays and fluorescence anisotropy, we re

63 eins, p.Q65X and p.Q119X, by electrophoretic mobility shift assays and immunoblot analyses indicated

64 The results of electrophoretic mobility shift assays and quantitative analysis of prgQ

65 y VqsM has been confirmed by electrophoretic mobility shift assays and quantitative real-time polymer

66 ognition, using quantitative electrophoretic mobility shift assays and reporter gene activation assay

67 Based on electrophoretic mobility shift assays and RNA footprinting, the H. pylor

68 Gel mobility shift assays and surface plasmon resonance anal

69 Using gel-mobility-shift assays and surface plasmon resonance spec

70 logs in terms of DNA binding (as revealed by mobility shift assays) and multimerization (as revealed

71 romatin immunoprecipitation, electrophoretic mobility shift assay, and both knockdown and overexpress

72 Through promoter mapping, electrophoretic mobility shift assay, and chromatin immunoprecipitation

73 Bioinformatic, electrophoretic mobility shift assay, and gene expression analysis found

74 on using UV melting studies, electrophoretic mobility shift assay, and RNase A footprinting.

75 promoter was demonstrated by electrophoretic mobility shift assay, and the MisR binding sequences wer

76 Promoter deletion analysis, electrophoresis mobility shift assays, and chromatin immunoprecipitation

77 luciferase reporter assays, electrophoretic mobility shift assays, and chromatin immunoprecipitation

78 terial one-hybrid screening, electrophoretic mobility shift assays, and coimmunoprecipitation experim

79 d by using a promoter truncation series, gel mobility shift assays, and DNase I footprinting.

80 h in vitro, as determined by electrophoretic mobility shift assays, and in cells, as determined by Ch

81 validated, both in vitro, by electrophoretic mobility shift assays, and in vivo, by chromatin immunop

82 nding site was defined using electrophoretic mobility shift assays, and its importance was investigat

83 romatin immunoprecipitation, electrophoretic mobility shift assays, and luciferase reporter assays we

84 sing saturation mutagenesis, electrophoretic mobility shift assays, and RNA-sequencing profiling of c

85 romatin immunoprecipitation, electrophoretic mobility shift assays, and VE-cadherin-luciferase report

86 sensitive acetyl transferase electrophoretic mobility shift assay applicable both for kinetic analysi

87 Electrophoretic mobility shift assay as well as chromatin immunoprecipit

88 Moreover, as determined by electrophoretic mobility shift assays, BioR binds the predicted operator

89 Electrokinetic preconcentration coupled with mobility shift assays can give rise to very high detecti

90 Using EMSA (electrophoretic mobility shift assay), ChIP (chromatin immunoprecipitati

91 e reporter luciferase assay, electrophoretic mobility shift assay, chromatin immunoprecipitation assa

92 Co-transfection analyses, electrophoretic mobility shift assays, chromatin immunoprecipitation, an

93 We also performed electrophoretic mobility shift assays, competition experiments and DNase

94 atin immunoprecipitation and electrophoretic mobility shift assays confirm are bound by Hand2 and Pho

95 Electrophoretic mobility shift assay confirmed that STAT3 bound to the m

96 Furthermore, electrophoretic mobility shift assays confirmed specific binding of Fur

97 Gel mobility shift assays confirmed that CcrR directly binds

98 atin immunoprecipitation and electrophoretic mobility shift assay data revealed that FOXO 3a regulate

99 Electrophoretic mobility shift assays demonstrate that cFos distinctly i

100 ents, mutation analyses, and electrophoretic mobility shift assays demonstrate that the sequence CGAC

101 Electrophoretic mobility shift assay demonstrated that Foxo1 suppressed

102 ent with these observations, electrophoretic mobility shift assay demonstrated that phenylmethimazole

103 Transactivation analysis and electrophoretic mobility shift assay demonstrated that PtrWNDs and EgWND

104 RNA electrophoresis mobility shift assays demonstrated a direct interaction

105 Electrophoretic mobility shift assays demonstrated decreased binding of

106 Electrophoretic mobility shift assays demonstrated increased NFAT-DNA bi

107 Electrophoretic mobility shift assays demonstrated that CcpE binds to th

108 Electrophoretic mobility shift assays demonstrated that CmHNF-4 binds to

109 Electrophoretic mobility shift assays demonstrated that FadR binds to th

110 Electrophoretic mobility shift assays demonstrated that hFXR-K210R and -

111 Electrophoretic mobility shift assays demonstrated that IolR recognized

112 Electrophoretic mobility shift assays demonstrated that nuclear extracts

113 Electrophoretic mobility shift assays demonstrated that the CcpA DNA bin

114 Electrophoretic mobility shift assays demonstrated that the four predict

115 Electrophoretic mobility shift assays demonstrated that these same trans

116 Electrophoretic mobility shift assays demonstrated that VtlR binds direc

117 In vitro electrophoretic mobility shift assays demonstrated the potential functio

118 Gel mobility-shift assays demonstrated that assembly of the

119 Electrophoretic mobility shift assay documented the activation of NF-kap

120 Electrophoretic mobility shift assay (EMSA) analysis disclosed that SarR

121 ese values were confirmed by electrophoretic mobility shift assay (EMSA) analysis, which also suggest

122 ciferase reporter assays and electrophoretic mobility shift assay (EMSA) analysis.

123 Here, we use electrophoretic mobility shift assay (EMSA) and atomic force microscopy

124 Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipit

125 Using electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipit

126 ing site as determined by an electrophoretic mobility shift assay (EMSA) and DNase I protection.

127 Using electrophoretic mobility shift assay (EMSA) and isothermal titration cal

128 Electrophoretic mobility shift assay (EMSA) experiments using an IE62 fr

129 for our in vivo studies and electrophoretic mobility shift assay (EMSA) for our in vitro studies, we

130 int mutation analysis and an electrophoretic mobility shift assay (EMSA) suggested that SknR function

131 We performed electrophoretic mobility shift assay (EMSA) using wild-type sequence der

132 Second, electrophoretic mobility shift assay (EMSA) was used to demonstrate the

133 Electrophoretic mobility shift assay (EMSA) was used to identify SNPs th

134 g enzyme-1 (BACE1) genes for electrophoretic mobility shift assay (EMSA) with different fragments of

135 gion were demonstrated in an electrophoretic mobility shift assay (EMSA), and a Mur binding site was

136 immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), and luciferase assays revea

137 the Bdnf gene, we performed electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitati

138 Using electrophoretic mobility shift assay (EMSA), purified LsrR and CRP prote

139 ing, as assessed in vitro by electrophoretic mobility shift assay (EMSA), revealed that a 14-bp seque

140 al repeat DNA as assessed by electrophoretic mobility shift assay (EMSA), the mutations did not disru

141 nd ICB2 was studied using an electrophoretic mobility shift assay (EMSA).

142 promoter was demonstrated by electrophoretic mobility shift assay (EMSA).

143 Electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipi

144 munoprecipitation (ChIP) and electrophoretic mobility shift assays (EMSA) experiments showed that ER8

145 Electrophoretic mobility shift assays (EMSA) indicated that a cellular f

146 FINDINGS: Luciferase assays, electrophoretic mobility shift assays (EMSA), and RNA expression by RT-P

147 Using recombinant ArsR in electrophoretic mobility shift assays (EMSA), we localized binding to a

148 bind TR DNA, as assessed by electrophoretic mobility shift assays (EMSA).

149 leotide library by employing electrophoretic mobility shift assays (EMSA).

150 o bound TR DNA as assayed by electrophoretic mobility shift assays (EMSA).

151 A binding with the use of an electrophoretic mobility-shift assay (EMSA) and confocal microscopy.

152 Additionally, electrophoretic mobility shift assays (EMSAs) and DNase I footprinting w

153 Electrophoretic mobility shift assays (EMSAs) confirmed binding of Rep t

154 ility and efflux assays, and electrophoretic mobility shift assays (EMSAs) confirmed compromised affi

155 Importantly, electrophoretic mobility shift assays (EMSAs) determined that a recombin

156 platform for high-throughput electrophoretic mobility shift assays (EMSAs) for identification and cha

157 Electrophoretic mobility shift assays (EMSAs) identified positive DNA-pr

158 tigen, we introduce affinity electrophoretic mobility shift assays (EMSAs) in a high-throughput forma

159 Electrophoretic mobility shift assays (EMSAs) revealed that the overexpr

160 Western blot analysis and electrophoretic mobility shift assays (EMSAs) showed that TC-EC contact

161 formed EA-binding assays and electrophoretic mobility shift assays (EMSAs) to elucidate a mechanism f

162 Electrophoretic mobility shift assays (EMSAs) were performed to investig

163 Electrophoretic mobility shift assays (EMSAs) were used to prove that H.

164 ctor binding was analyzed by electrophoretic mobility shift assays (EMSAs) with Jurkat T-cell nuclear

165 nmoR, which was confirmed by electrophoretic mobility shift assays (EMSAs) with the purified NmoR pro

166 protein purification steps, electrophoretic mobility shift assays (EMSAs), and mass spectrometry ana

167 e fusion proteins, and using electrophoretic mobility shift assays (EMSAs), the IHFalpha-IHFbeta prot

168 s, including SW blotting and electrophoretic mobility shift assays (EMSAs).

169 The microfluidic mobility shift assay establishes a scalable format for t

170 A combination of electrophoretic mobility shift assay experiments and bioinformatic analy

171 Electrophoretic mobility shift assay experiments demonstrated RTCS bindi

172 th infected cell extracts in electrophoretic mobility shift assay experiments, (iv) supershift assays

173 Luciferase reporter and electrophoretic-mobility shift assay for the FUT6 variant rs78060698 usi

174 Gel mobility shift assays further demonstrated that DDX1 for

175 Electrophoretic mobility shift assay gel shift patterns suggested that a

176 scence, CD spectroscopy, NMR, and native gel mobility shift assays (GMSAs).

177 ATF3 promoter activity, and electrophoretic mobility shift assay identified this region as a core se

178 es, mutagenesis studies, and electrophoretic mobility shift assays identified a PPARalpha response el

179 dow for functional impact on electrophoretic mobility shift assay identifies rs806371 as a novel regu

180 8378; multiplexed competitor electrophoretic mobility shift assays implicated FOXA as the protein.

181 Using electrophoretic mobility shift assays in HeLa cell extracts, we show tha

182 regulation of Shp by Vdr using reporter and mobility shift assays in transfected human embryonic kid

183 Electrophoretic mobility shift assay indicated that P-RhpR has a higher

184 Electrophoretic mobility shift assays indicated that BpaB also binds wit

185 However, in contrast to E. coli, gel mobility shift assays indicated that neither E. coli nor

186 Electrophoretic mobility shift assays indicated that specific nuclear pr

187 Furthermore, electrophoretic mobility shift assays indicated the presence of an activ

188 ssays, bind KLF16 in vivo In electrophoretic mobility shift assays, KLF16 binds specifically to a sin

189 etion assay of IL-17, and by electrophoretic mobility shift assay of activating protein-1 (AP-1).

190 reporter into cell lines or electrophoretic mobility shift assay of lysate.

191 Electrophoretic mobility shift assays on the shortlist detected allele-s

192 with mutational analysis and electrophoretic mobility shift assays, our results provide insights into

193 In mobility shift assays, PHR1 and its close homologue PHL1

194 dies utilizing a pulse-chase electrophoretic mobility shift assay protocol revealed that mutating eit

195 Electrophoretic mobility shift assays provide further evidence that A. p

196 es upon modulation of HOTAIR Electrophoretic mobility shift assays provided further evidence that HOT

197 In the electrophoretic mobility shift assay, purified recombinant Reb1p was sho

198 Electrophoretic mobility shift assays, quantitative reverse transcriptio

199 Using electrophoretic mobility shift assay, real-time PCR, and immunoblotting,

200 by coimmunoprecipitation and electrophoretic mobility shift assays, respectively.

201 Electrophoretic mobility shift assay results demonstrate Myc-Max heterod

202 Electrophoretic mobility shift assays reveal two discrete complexes with

203 ated in resistant plants and electrophoretic mobility shift assay revealed sequence-specific binding

204 An electrophoretic mobility shift assay revealed similarity between human a

205 Electrophoretic mobility shift assay revealed that PMA stimulated DNA bi

206 Electrophoretic mobility shift assays revealed a direct binding of KLF9

207 Electrophoretic mobility shift assays revealed direct binding of B. anth

208 Electrophoretic mobility shift assays revealed increased binding of 8S m

209 Eletrophoretic mobility shift assays revealed increased binding of unme

210 In this study, electrophoretic gel mobility shift assays revealed specific DNA-protein bind

211 DNA mobility shift assays revealed specific protein complexe

212 Electrophoretic mobility shift assays revealed that ChrA specifically bi

213 Electrophoretic mobility shift assays revealed that FKPB51 overexpressio

214 Moreover, mobility shift assays revealed that Msn4 binds beta-oxid

215 Electrophoretic mobility shift assays revealed that NFATc2 and CSL bind

216 Electrophoretic mobility shift assays revealed that RegX3 binds directly

217 Electrophoretic mobility shift assays revealed that SarX protein bound t

218 east one-hybrid analysis and electrophoretic mobility shift assays revealed that the transmembrane do

219 Electrophoretic mobility shift assays revealed that Tim enhances DDX11 b

220 RNA electrophoretic mobility shift assays (RNA-EMSA) were used to confirm th

221 Electrophoretic mobility shift assays show that Mn(II) restores DNA bind

222 Electrophoretic mobility shift assays show that RTV1 binds to DNA in vit

223 Electrophoretic mobility shift assays show that the K protein binds to a

224 Electrophoretic mobility shift assay showed RUNX1 binding to each site.

225 An electrophoretic mobility shift assay showed that Arn prevents H-NS from

226 Electrophoretic mobility shift assay showed that OsbZIP48 binds directly

227 Electrophoretic mobility shift assay showed that PU.1 protein bound Dect

228 evealed VDR-dependent inhibition of SHP, and mobility shift assays showed direct binding of VDR to en

229 However, electrophoresis mobility shift assays showed less binding of HNF-3beta t

230 Electrophoretic mobility shift assays showed that AaNAC2, AaNAC3, and Aa

231 -hybrid system technique and electrophoretic mobility shift assays showed that AioR interacts with th

232 ) one-hybrid experiments and electrophoresis mobility shift assays showed that AtNAP could physically

233 In this study, electrophoretic mobility shift assays showed that AtWRKY30 binds with hi

234 Electrophoretic mobility shift assays showed that Fur binds upstream of

235 Immunoprecipitation-qPCR and electrophoretic mobility shift assays showed that MdMYB88/MdMYB124 act a

236 ophyll cell protoplasts, and electrophoretic mobility shift assays showed that NAP can bind directly

237 Gene expression and electrophoretic mobility shift assays showed that the 5.3-kDa antimicrob

238 Electrophoretic mobility shift assays showed that the CRR1 SBP domain bi

239 Mobility shift assays showed that the transcription fact

240 Electrophoretic mobility shift assay shows that unphosphorylated HP0166

241 otein interaction studies by electrophoretic mobility shift assay suggested hypoxia response and an a

242 Mobility shift assays suggested that E2F interacts with

243 these interact with ABI4 in electrophoretic mobility shift assays, suggesting that sequence recognit

244 We introduce a microfluidic mobility shift assay that enables precise and rapid quan

245 We showed by electrophoretic mobility shift assay that the C terminus of KNL2 binds D

246 , we have recapitulated our findings using a mobility shift assay that was developed and employed by

247 We also show through electrophoretic mobility shift assays that OsARID3 specifically binds to

248 t fluorescence quenching and electrophoretic mobility shift assays that probe siRNA binding by the di

249 We demonstrate using electrophoretic mobility shift assays that Rv0678 binds to the mmpS5-mmp

250 vitro dimethyl sulfate footprinting and gel mobility shift assays, that DnaA(L366K) in either nucleo

251 When examined by electrophoretic mobility shift assay, the triterpenoid suppressed nuclea

252 However, based on electrophoretic mobility shift assays, the divergent CTRs do appear to p

253 In electrophoretic mobility shift assays, the purified rPG2212 protein did

254 In addition to electrophoretic mobility shift assays, this model was corroborated by fu

255 In this study, we used electrophoretic mobility shift assay to analyze 46 arylstibonic acids fo

256 d forms of CpsA were used in electrophoretic mobility shift assays to characterize the ability to bin

257 riophage lambda Cro and used electrophoretic mobility shift assays to compare binding of each variant

258 We used deep sequencing and electrophoretic mobility shift assays to derive in vitro GR binding affi

259 ions, in situ hybridization, electrophoretic mobility shift assays to determine binding sites in targ

260 In a previous study, we used gel mobility shift assays to determine that BreR binds at tw

261 DNase hypersensitivity, and electrophoretic mobility shift assays to study protein-DNA binding, we i

262 We used electrophoretic mobility shift assay, transient transcriptional activati

263 tly reduced ability to bind 3' and 5' RNA in mobility shift assays, use the DNA target to prime rever

264 etry of a band excised after electrophoretic mobility shift assay using a ZTRE probe.

265 ear transcription factors by electrophoretic mobility shift assay using digoxigenin (DIG)-labeled pro

266 Electrophoretic mobility shift assays using mouse retinal nuclear extrac

267 Electrophoretic mobility shift assays using the ilvE promoter and a puri

268 Mobility-shift assays using a control RNA detected an RN

269 Gel mobility shift assays validated the identity of the APUM

270 Electrophoretic mobility shift assays verified formation of a sandwich c

271 An electrophoretic mobility shift assay was used to determine that the GT3

272 A gel mobility shift assay was used to examine the effect of p

273 Use of the methods for electrophoretic mobility shift assays was demonstrated for binding of th

274 , NMR, microcalorimetry, and electrophoretic mobility shift assay), we have characterized the structu

275 Using a phospho-protein mobility shift assay, we demonstrate that WRKY33 is phos

276 Using a gel mobility shift assay, we found that HBD2 bound to a rang

277 sorbent assay (ELISA) and an electrophoretic mobility shift assay, we found that the NF-kappaB subuni

278 atin immunoprecipitation and electrophoretic mobility shift assay, we show that TH has a direct recep

279 By electrophoretic mobility shift assays, we confirmed binding of FOXA prot

280 of in vitro translation and electrophoretic mobility shift assays, we demonstrate that a PCBP/nsp1be

281 Using RNase digestion, DNAzyme, and RNA mobility shift assays, we demonstrate the absence of nak

282 luorescence polarization and electrophoretic mobility shift assays, we demonstrate the recognition of

283 te-directed mutagenesis, and electrophoretic mobility shift assays, we identified a GLI2 binding site

284 Using electrophoretic mobility shift assays, we identified CREB as the regulat

285 By electrophoretic mobility shift assays, we identified four additional Sma

286 Using reporter gene and electrophoretic mobility shift assays, we identify an 11-bp fragment of

287 Using electrophoretic mobility shift assays, we observed differential CEBPB bi

288 By electrophoretic mobility shift assays, we show weaker binding of protein

289 on resonance diffraction and electrophoretic mobility shift assays were consistent with PARTICLE trip

290 In silico analysis and electrophoretic mobility shift assays were used to assess SNP function.

291 Electrophoretic mobility shift assays were used to assess the binding of

292 Gel mobility shift assays were used to measure the binding a

293 ption were also reflected in electrophoretic mobility shift assays where CcpE bound to the citB promo

294 H-NS/ToxT binding sites was observed in gel mobility shift assays, where ToxT was found to displace

295 investigated by competitive electrophoretic mobility shift assay, which revealed that the two AC-ric

296 ion factor-binding sites and electrophoretic mobility shift assays with MCF-7 nuclear protein demonst

297 Electrophoretic mobility shift assays with PARP-1-specific antibody loca

298 Electrophoretic mobility shift assays with purified His(10)-MrpC2 and Fr

299 by DNase I footprinting and electrophoretic mobility shift assays, with some DNA-binding capacity be

300 ng yeast 3 hybrid assays and electrophoretic mobility shift assays, Zar2 was shown to bind specifical